ES374929A1 - Procedimiento para la preparacion de l-3-(3,4-dihidroxife- nil)-alamina. - Google Patents
Procedimiento para la preparacion de l-3-(3,4-dihidroxife- nil)-alamina.Info
- Publication number
- ES374929A1 ES374929A1 ES374929A ES374929A ES374929A1 ES 374929 A1 ES374929 A1 ES 374929A1 ES 374929 A ES374929 A ES 374929A ES 374929 A ES374929 A ES 374929A ES 374929 A1 ES374929 A1 ES 374929A1
- Authority
- ES
- Spain
- Prior art keywords
- salts
- group
- dihydroxyphenyl
- racemate
- alanine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04C—STRUCTURAL ELEMENTS; BUILDING MATERIALS
- E04C2/00—Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels
- E04C2/02—Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by specified materials
- E04C2/26—Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by specified materials composed of materials covered by two or more of groups E04C2/04, E04C2/08, E04C2/10 or of materials covered by one of these groups with a material not specified in one of the groups
-
- E—FIXED CONSTRUCTIONS
- E04—BUILDING
- E04C—STRUCTURAL ELEMENTS; BUILDING MATERIALS
- E04C2/00—Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels
- E04C2/30—Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by the shape or structure
- E04C2/38—Building elements of relatively thin form for the construction of parts of buildings, e.g. sheet materials, slabs, or panels characterised by the shape or structure with attached ribs, flanges, or the like, e.g. framed panels
Landscapes
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Architecture (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Structural Engineering (AREA)
- Civil Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78756368A | 1968-12-27 | 1968-12-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES374929A1 true ES374929A1 (es) | 1972-04-01 |
Family
ID=25141894
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES374929A Expired ES374929A1 (es) | 1968-12-27 | 1969-12-26 | Procedimiento para la preparacion de l-3-(3,4-dihidroxife- nil)-alamina. |
Country Status (13)
Country | Link |
---|---|
US (1) | US3734952A (es) |
BE (1) | BE743496A (es) |
CH (1) | CH529098A (es) |
CS (1) | CS153057B2 (es) |
DE (1) | DE1964422A1 (es) |
ES (1) | ES374929A1 (es) |
FR (1) | FR2027208A1 (es) |
GB (1) | GB1292975A (es) |
HU (1) | HU162412B (es) |
IE (1) | IE33679B1 (es) |
IL (1) | IL33533A0 (es) |
NL (1) | NL6919271A (es) |
SU (1) | SU379085A3 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH562199A5 (es) * | 1970-10-30 | 1975-05-30 | Hoffmann La Roche | |
US4005127A (en) * | 1971-03-08 | 1977-01-25 | Monsanto Company | L-Dopa process and intermediates |
US3941831A (en) * | 1973-09-10 | 1976-03-02 | G. D. Searle & Co. | Resolution of alkyl esters of DL-phenylalanine |
US3891696A (en) * | 1973-11-02 | 1975-06-24 | Interx Research Corp | Novel, transient pro-drug forms of l-dopa |
US4151198A (en) * | 1978-06-02 | 1979-04-24 | American Cyanamid Company | Resolution of N-acyl-DL (+)-phenylalanines |
US4833273A (en) * | 1986-02-03 | 1989-05-23 | Warner-Lambert Company | Process for the resolution of 1-aminoindanes |
AU2003233147B2 (en) | 2002-05-13 | 2008-03-06 | Arexis Ab | Autoimmune conditions and NADPH oxidase defects |
-
1968
- 1968-12-27 US US00787563A patent/US3734952A/en not_active Expired - Lifetime
-
1969
- 1969-12-09 CH CH1829869A patent/CH529098A/de not_active IP Right Cessation
- 1969-12-14 IL IL33533A patent/IL33533A0/xx unknown
- 1969-12-16 GB GB61248/69A patent/GB1292975A/en not_active Expired
- 1969-12-22 BE BE743496D patent/BE743496A/xx unknown
- 1969-12-23 CS CS849269A patent/CS153057B2/cs unknown
- 1969-12-23 IE IE1709/69A patent/IE33679B1/xx unknown
- 1969-12-23 DE DE19691964422 patent/DE1964422A1/de active Pending
- 1969-12-23 NL NL6919271A patent/NL6919271A/xx unknown
- 1969-12-24 HU HUHO1247A patent/HU162412B/hu unknown
- 1969-12-24 FR FR6944895A patent/FR2027208A1/fr not_active Withdrawn
- 1969-12-25 SU SU1389864A patent/SU379085A3/ru active
- 1969-12-26 ES ES374929A patent/ES374929A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
NL6919271A (es) | 1970-06-30 |
IE33679B1 (en) | 1974-09-18 |
CH529098A (de) | 1972-10-15 |
SU379085A3 (es) | 1973-04-18 |
US3734952A (en) | 1973-05-22 |
CS153057B2 (es) | 1974-02-22 |
IE33679L (en) | 1970-06-27 |
BE743496A (es) | 1970-06-22 |
IL33533A0 (en) | 1970-02-19 |
FR2027208A1 (es) | 1970-09-25 |
HU162412B (es) | 1973-02-28 |
GB1292975A (en) | 1972-10-18 |
DE1964422A1 (de) | 1970-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES374929A1 (es) | Procedimiento para la preparacion de l-3-(3,4-dihidroxife- nil)-alamina. | |
CH460044A (de) | Verfahren zur Herstellung neuer heterocyclischer Verbindungen | |
AT293366B (de) | Verfahren zur Herstellung von L-3-(3,4-Dihydroxyphenyl)-alanin | |
CH505837A (de) | Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Piperazinderivaten | |
ES388881A1 (es) | Procedimiento para la preparacion de 1-(2-nitrilafenoxi)-2-hidroxi-3-etilaminopropano racemicos u opticamente activo. | |
BE798178A (fr) | Derives d'acides phosphoniques substitues utilisables notamment comme agents ignifugeants | |
AT325631B (de) | Verfahren zur herstellung von 1-(5-alkyl-1,3,4-thiadiazol-2-yl)-1,3-dialkyl-harnstoffen | |
AT269137B (de) | Verfahren zur Herstellung neuer Oxazolidinderivate | |
ES385918A1 (es) | Procedimiento para la preparacion de nuevos acilderivados de bis-arilalcohilaminas sustituidas. | |
ES378205A1 (es) | Procedimiento para la preparacion de nuevos 2-amino-5-ni- trotiazoles sustituidos en el grupo amino. | |
GB1244682A (en) | Anti-viral agents | |
CH529775A (de) | Verfahren zur Herstellung von 2-substituierten 3-Chlor-1,2,4-thiaimidazol-5-onen | |
FR2096376A1 (en) | Phenyl alanine derivs for treating parkinsonism | |
AT306052B (de) | Verfahren zur Herstellung von neuer (cis-1,2-Epoxypropyl)-phosphonsäure oder entsprechenden Salzen oder Esterderivaten davon | |
ES428270A1 (es) | Procedimiento de preparacion del sec. butil-2-metil-1 nitro-5 imidazol. | |
AT265522B (de) | Verfahren zur Herstellung von stabilen wässerigen Injektionslösungen von 1-Alkyl-2-pyridinium-aldoxim-salzen | |
CH503751A (de) | Verfahren zur Herstellung neuer Alkylammoniumsalze von 1,2,4-Triazolen | |
AT308742B (de) | Verfahren zur Herstellung neuer heterocyclischer Verbindungen oder Salze davon | |
AT313258B (de) | Verfahren zur Herstellung von optisch aktivem 3,4-Dihydroxyphenylalanin | |
ES392899A1 (es) | Un metodo de preparar una composicion herbicida selectiva. | |
CH515937A (de) | Verfahren zur Herstellung von Mischungen aus (+)- und (-)- Enantiomeren oder dem (+/-)-Racemat neuer (cis-1,2-Epoxypropyl)-phosphonsäurederivate | |
CH555349A (de) | Verfahren zur herstellung neuer substituierter isothiocyanate des benztriazols mit hoher antimikrobieller wirksamkeit. | |
AT270081B (de) | Verfahren zur Herstellung von neuen racemischen oder optisch aktiven Scopolammoniumsalzen | |
ES420716A1 (es) | Procedimiento para la obtencion de dibenzazecinas. | |
ES353377A1 (es) | Mejoras introducidas en un procedimiento para la elaboracion de un material de diazotipia de un solo componente |